GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Market Cap

Kolon Life Science (XKRX:102940) Market Cap : ₩250,501 Mil (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kolon Life Science's share price for the quarter that ended in Mar. 2024 was ₩22850. Kolon Life Science's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 11 Mil. Therefore, Kolon Life Science's market cap for the quarter that ended in Mar. 2024 was ₩260,773 Mil.

Kolon Life Science's quarterly market cap declined from Sep. 2023 (₩299,005 Mil) to Dec. 2023 (₩293,299 Mil) and declined from Dec. 2023 (₩293,299 Mil) to Mar. 2024 (₩260,773 Mil).

Kolon Life Science's annual market cap declined from Dec. 2021 (₩493,059 Mil) to Dec. 2022 (₩312,700 Mil) and declined from Dec. 2022 (₩312,700 Mil) to Dec. 2023 (₩293,299 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kolon Life Science's Enterprise Value for Today is ₩350,802 Mil.


Kolon Life Science Market Cap Historical Data

The historical data trend for Kolon Life Science's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Market Cap Chart

Kolon Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 205,773.61 331,175.81 493,058.65 312,699.76 293,298.68

Kolon Life Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 385,739.12 345,795.72 299,004.88 293,298.68 260,773.34

Competitive Comparison of Kolon Life Science's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Kolon Life Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kolon Life Science's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kolon Life Science's Market Cap distribution charts can be found below:

* The bar in red indicates where Kolon Life Science's Market Cap falls into.



Kolon Life Science Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Kolon Life Science's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=₩25700*11.4124
=₩293,299

Kolon Life Science's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₩22850*11.4124
=₩260,773

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kolon Life Science  (XKRX:102940) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Kolon Life Science Market Cap Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Kolon Life Science (XKRX:102940) Business Description

Traded in Other Exchanges
N/A
Address
110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR
Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines